HealthDay on MSN1d
Clinical Guidelines Updated for Evaluation, Management, Treatment of CKD
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Renal & Urology News21h
KDIGO Guideline Takeaways for Pediatric Chronic Kidney Disease
Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...
Clinical guidelines updated for evaluation, management, treatment of chronic kidney disease
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Medscape6d
Major Changes Highlighted in New CKD Management Guidelines
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
The American Journal of Managed Care10d
New Guideline Updates to Slow CKD Progression and Reduce Cardiovascular Risk
Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...
MedPage Today on MSN11d
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors
Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Medical Dialogues9d
Updated chronic kidney disease management guidelines recommend SGLT2 inhibitors regardless of diabetes or kidney disease type
Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...